Skip to content Skip to footer
Truxima: Benefits, Reviews, Info, Side Effects!
Rx Details
Truxima
Rituximab, MabThera, Ritemvia, Rixathon
Rituximab
Prescription
Biosimilar
Drugs
Biosimilar
rituximab biosimilar, treats certain types of cancer, treats rheumatoid arthritis, treats granulomatosis with polyangiitis, treats microscopic polyangiitis, reduces inflammation, targets CD20 protein on B cells, helps in depleting B cells, used in non-Hodgkin’s lymphoma, used in chronic lymphocytic leukemia
Back Pain, Chills, Cough, Dizziness, Fever, Headache, Increased Risk Of Infections, Infusion-Related Reactions, Itching, Low Blood Pressure, Nausea, Rash, Throat Irritation, Weakness
Truxima is a biosimilar to rituximab, which is a monoclonal antibody used to treat certain autoimmune diseases and types of cancer. The dosage of Truxima can vary depending on the condition being treated. Here are some general guidelines: 1. **Non-Hodgkin’s Lymphoma (NHL):** – For previously untreated follicular, CD20-positive, B-cell NHL, the typical dose is 375 mg/m² intravenously on Day 1 of each cycle of chemotherapy. – For relapsed or refractory, low-grade or follicular, CD20-positive, B-cell NHL, the dose is usually 375 mg/m² intravenously once weekly for 4 or 8 doses. 2. **Chronic Lymphocytic Leukemia (CLL):** – The standard dose is 375 mg/m² intravenously on the day prior to the initiation of chemotherapy, then 500 mg/m² on Day 1 of each cycle for 6 cycles. 3. **Rheumatoid Arthritis:** – Typically, two 1000 mg intravenous infusions separated by two weeks, in combination with methotrexate. 4. **Granulomatosis with Polyangiitis and Microscopic Polyangiitis:** – The usual regimen is 375 mg/m² intravenously once weekly for 4 weeks. It’s important to note that these are general guidelines and the exact dosage and schedule should be determined by a healthcare professional based on the individual patient’s condition and response to treatment. Always consult with a healthcare provider for medical advice and before starting any new treatment.
Rheumatoid arthritis, non-hodgkin’s lymphoma, chronic lymphocytic leukemia, granulomatosis with polyangiitis, microscopic polyangiitis
Generally well-tolerated, with common side effects including infusion reactions and infections.
No Interactions Reported
$500 – $700
$3,000

A Synopsis of

Truxima

Truxima is a medication that falls under the category of biosimilar drugs, specifically a biosimilar to rituximab. It is used in the treatment of various conditions, including non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and granulomatosis with polyangiitis. Truxima works by targeting and destroying specific cells in the body that are overactive or abnormal, such as cancer cells or cells involved in autoimmune diseases.

As a medical professional, it is important to understand the benefits and potential side effects of Truxima in order to provide the best care for your patients. Truxima has been shown to be effective in treating the aforementioned conditions, often leading to improved outcomes and quality of life for patients. However, like any medication, Truxima does come with potential side effects that should be monitored closely.

Common side effects of Truxima may include infusion reactions, infections, low blood cell counts, and increased risk of developing certain types of cancer. It is important to educate patients about these potential side effects and monitor them closely during treatment. Additionally, patients should be informed about the importance of regular blood tests to monitor their response to the medication and any potential side effects.

Overall, Truxima is a valuable medication in the treatment of various conditions, but it is important for medical professionals to be knowledgeable about its uses, benefits, and potential risks in order to provide the best care for their patients. By staying informed and closely monitoring patients during treatment, we can help ensure the best possible outcomes for those receiving Truxima therapy.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN